Skip to content

Dalmolin Group's workflow for pre-processing, alignment and quantification of bulk RNA-seq data

License

Notifications You must be signed in to change notification settings

dalmolingroup/bulkrna

Repository files navigation

Nextflow run with conda run with docker run with singularity

Introduction

dalmolingroup/bulkrna is an analysis pipeline for pre-processing, alignment and quantification of bulk RNA-Seq data.

The pipeline is built using Nextflow, a workflow tool to run tasks across multiple compute infrastructures in a very portable manner. It uses Docker/Singularity containers making installation trivial and results highly reproducible. The Nextflow DSL2 implementation of this pipeline uses one container per process which makes it much easier to maintain and update software dependencies. Where possible, these processes have been submitted to and installed from nf-core/modules in order to make them available to all nf-core pipelines, and to everyone within the Nextflow community!

Pipeline summary

  1. Read QC (FastQC)
  2. Read trimming (fastp)
  3. Alignment and quantification (kallisto)
  4. Import quantifications into a count matrix, at gene and transcript level(tximport)
  5. Present QC for trimmed reads and alignment (MultiQC)

Quick Start

  1. Install Nextflow (>=22.10.1)

  2. Install any of Docker, Singularity (you can follow this tutorial), Podman, Shifter or Charliecloud for full pipeline reproducibility (you can use Conda both to install Nextflow itself and also to manage software within pipelines. Please only use it within pipelines as a last resort; see docs).

  3. Download the pipeline and test it on a minimal dataset with a single command:

    nextflow run dalmolingroup/bulkrna -profile test,YOURPROFILE --outdir <OUTDIR>

    For example, run the test with Docker:

    nextflow run dalmolingroup/bulkrna -profile test,docker --outdir bulkrna_results

    Note that some form of configuration will be needed so that Nextflow knows how to fetch the required software. This is usually done in the form of a config profile (YOURPROFILE in the example command above). You can chain multiple config profiles in a comma-separated string.

    • The pipeline comes with config profiles called docker, singularity, podman, shifter, charliecloud and conda which instruct the pipeline to use the named tool for software management. For example, -profile test,docker.
    • Please check nf-core/configs to see if a custom config file to run nf-core pipelines already exists for your Institute. If so, you can simply use -profile <institute> in your command. This will enable either docker or singularity and set the appropriate execution settings for your local compute environment.
    • If you are using singularity, please use the nf-core download command to download images first, before running the pipeline. Setting the NXF_SINGULARITY_CACHEDIR or singularity.cacheDir Nextflow options enables you to store and re-use the images from a central location for future pipeline runs.
    • If you are using conda, it is highly recommended to use the NXF_CONDA_CACHEDIR or conda.cacheDir settings to store the environments in a central location for future pipeline runs.
  4. Start running your own analysis!

    nextflow run dalmolingroup/bulkrna --input samplesheet.csv --outdir <OUTDIR> --transcriptome <PATH TO TRANSCRIPTOME FASTA> --gtf <PATH TO GTF FILE> -profile <docker/singularity/podman/shifter/charliecloud/conda/institute>

Credits

dalmolingroup/bulkrna was originally written by João Cavalcante.

Contributions and Support

If you would like to contribute to this pipeline, please see the contributing guidelines.

Citations

An extensive list of references for the tools used by the pipeline can be found in the CITATIONS.md file.

This pipeline uses code and infrastructure developed and maintained by the nf-core community, reused here under the MIT license.

The nf-core framework for community-curated bioinformatics pipelines.

Philip Ewels, Alexander Peltzer, Sven Fillinger, Harshil Patel, Johannes Alneberg, Andreas Wilm, Maxime Ulysse Garcia, Paolo Di Tommaso & Sven Nahnsen.

Nat Biotechnol. 2020 Feb 13. doi: 10.1038/s41587-020-0439-x.